Suppr超能文献

用OKY - 046抑制血栓素A合成可通过延长大鼠低温机器灌注时间来改善肝脏保存效果。

Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.

作者信息

Xu Hongzhi, Lee Charles Y, Clemens Mark G, Zhang Jian X

机构信息

Department of Biology, University of North Carolia at Charlotte, Charlotte, North Carolina 28223, USA.

出版信息

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e212-20. doi: 10.1111/j.1440-1746.2007.05061.x. Epub 2007 Jul 20.

Abstract

BACKGROUND AND AIM

We previously reported that hypothermic machine perfusion (HMP) for liver preservation is feasible, but hepatic microcirculatory dysfunction and significant liver damage remain major obstacles in its application when the preservation is extended to 24 h. The underlying injury mechanism is not well understood. The present study sought to investigate the role of thromboxane A(2) (TXA(2)) in the pathogenesis of liver injury after prolonged HMP.

METHODS

Livers isolated from Sprague-Dawley rats were subjected to continuous machine perfusion with University of Wisconsin (UW) solution at a flow rate of 0.4 mL/min/g liver at 4 degrees C for 24 h. A specific TXA(2) synthase inhibitor, OKY-046 (OKY), was added to UW solution during the preservation period and to the Krebs-Henseleit buffer during reperfusion. The performance of the livers after preservation was evaluated using an isolated liver perfusion system with Krebs-Henseleit buffer at a flow rate of 15 mL/min at 37 degrees C for 30 min.

RESULTS

Prolonged HMP induced a significant release of TXA(2) into the portal circulation as indicated by markedly increased levels of TXB(2) in the perfusate during reperfusion (at 30 min, 1447.4 +/- 163.6 pg/mL vs 50.91 +/- 6.7 pg/mL for control). Inhibition of TXA(2) synthesis with OKY significantly decreased releases of TXA(2) (69.8 +/- 13.4 pg/mL) concomitant with reduced lactate dehydrogenase (LDH) releases (at 30 min, HMP + OKY: 144.9 +/- 27.9 U/L; HMP: 369.3 +/- 68.5 U/L; simple cold storage or SCS: 884.4 +/- 80.3 U/L), decreased liver wet/dry weight ratio (HMP + OKY vs SCS and HMP: 3.6 +/- 0.3 vs 4.4 +/- 0.1 and 3.9 +/- 0.2, respectively) and increased hyaluronic acid uptake (at 30 min, HMP + OKY vs SCS, HMP: 33.1 +/- 2.9% vs 13.9 +/- 3.6%, 18.6 +/- 2.4%, respectively). Liver histology also showed significant improvement in tissue edema and hepatocellular necrosis with OKY compared with HMP without OKY.

CONCLUSION

The results demonstrate that TXA(2) is involved in the development of hepatocellular injury induced by HMP, and inhibition of TXA(2) synthesis during preservation and reperfusion protects liver hepatocytes and sinusoidal endothelial cells from injuries caused by prolonged HMP.

摘要

背景与目的

我们之前报道过肝脏低温机器灌注(HMP)用于肝脏保存是可行的,但当保存时间延长至24小时时,肝脏微循环功能障碍和严重的肝损伤仍是其应用中的主要障碍。潜在的损伤机制尚不清楚。本研究旨在探讨血栓素A2(TXA2)在长时间HMP后肝损伤发病机制中的作用。

方法

从Sprague-Dawley大鼠分离的肝脏在4℃下以0.4 mL/分钟/克肝脏的流速用威斯康星大学(UW)溶液进行连续机器灌注24小时。在保存期向UW溶液中加入特异性TXA2合酶抑制剂OKY-046(OKY),并在再灌注时向Krebs-Henseleit缓冲液中加入。保存后肝脏的性能在37℃下以15 mL/分钟的流速用Krebs-Henseleit缓冲液通过离体肝脏灌注系统评估30分钟。

结果

长时间HMP导致TXA2大量释放进入门静脉循环,这表现为再灌注期间灌注液中TXB2水平显著升高(30分钟时,1447.4±163.6 pg/mL,而对照组为50.91±6.7 pg/mL)。用OKY抑制TXA2合成显著降低了TXA2的释放(69.8±13.4 pg/mL),同时乳酸脱氢酶(LDH)释放减少(30分钟时,HMP+OKY组:144.9±27.9 U/L;HMP组:369.3±68.5 U/L;单纯冷保存或SCS组:884.4±80.3 U/L),肝脏湿/干重比降低(HMP+OKY组与SCS组和HMP组相比分别为3.6±0.3 vs 4.4±0.1和3.9±0.2),透明质酸摄取增加(30分钟时,HMP+OKY组与SCS组、HMP组相比分别为33.1±2.9% vs 13.9±3.6%、18.6±2.4%)。肝脏组织学也显示与未用OKY的HMP相比,用OKY后组织水肿和肝细胞坏死有显著改善。

结论

结果表明TXA2参与了HMP诱导的肝细胞损伤的发生发展,在保存和再灌注期间抑制TXA2合成可保护肝脏肝细胞和肝窦内皮细胞免受长时间HMP所致的损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验